Recently, results from a phase 2a clinical trial for treating idiopathic pulmonary fibrosis (IPF), led by Dr. Xu Zuojun's team from the Department of Pulmonary and Critical Care Medicine at PUMCH, were published in the internationally prestigious medical journ...